Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-04

Clinical Trial Update: Probiotics for Reduction Of Markers In Subjects With Allergy [NA]

View source ↗

Summary

This completed clinical trial evaluated whether probiotics can reduce allergy-related biomarkers in participants with hay fever due to birch pollen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (probiotic)

Snippet

Sponsor: Rijnstate Hospital | Conditions: Hay Fever, Birch Pollen Allergy | NA | Status: COMPLETED